The evolving role of chemokines and their receptors in acute allograft rejection

Nephrology Dialysis Transplantation

Volumn 17, Issue 8, 2002, Pages 1374-1379

  Inston, Nicholas G ^a   Cockwell, Paul ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Acute allograft rejection; Chemokine receptors; Chemokines; Graft survival; Renal transplantation

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CX3C CHEMOKINE; CYCLOSPORIN; FRACTALKINE; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ACUTE DISEASE; ALLOTRANSPLANTATION; ANIMAL; GRAFT REJECTION; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

ACUTE DISEASE; ANIMALS; CHEMOKINES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; RECEPTORS, CHEMOKINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035993269     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.8.1374     Document Type: Article

References (64)

1. Improved graft survival after renal transplantation in the United States, 1988 to 1996
2. Predictive value of CD45RO positive T-helper lymphocyte subsets for acute cellular rejection during the early phase after kidney transplantation
3. In situ expression of tumour necrosis factor-alpha, interferon-gamma, and interleukin-2 receptors in renal allograft biopsies
4. The biochemistry and cell biology of antigen processing and presentation
5. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
6. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration
7. The biology of chemokines and their receptors
8. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines
9. Wall shear stress: The missing step for T cell transmigration?
10. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes
11. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory cells
12. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors
13. The chemokine system: Redundancy for robust outputs
14. Impaired monocyte migration and reduced Type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice
15. Defects in macrophage recruitment and host defence in mice lacking the CCR2 chemokine receptor
16. Targeted disruption of the β-chemokine receptor CCR1 protects against pancreatitis-associated lung injury
17. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
18. Integrating conflicting chemotactic signals: The role of memory in leukocyte navigation
19. Production and cytokine-mediated regulation of monocyte chemoatractant protein-1 by human proximal tubular epithelial cells
20. In situ analysis of CC chemokine mRNA in human glomerulonephritis
21. Synergistic effect of IL-1α, IFN-γ and TNF-α on RANTES production by human renal tubular epithelial cells in vitro
22. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
23. Differential expression of chemokine receptors and chemotactic responsiveness of Type 1 T helper cells
24. Lymphocyte-specific chemokine receptor CXCR3: Regulation, chemokine binding and gene localization
25. The chemokine receptor CXCR3 mediates rapid and shear resistant-induction of effector T lymphocytes by the chemokines IP-10 and Mig
26. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells
27. Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
28. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
29. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells
30. Chemoattraction of T cells expressing CCR5 and CXCR3 by proximal tubular epithelial cell chemokines
31. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides
32. Intragraft expression of chemokine gene occurs early during acute rejection of allogeneic cardiac grafts
33. T cell infiltration into class II MHC-disparate allografts and acute allograft rejection is dependent on the IFN-gamma induced chemokine Mig
34. Donor derived IP-10 initiates development of acute allograft rejection
35. Infiltration of allografts by natural killer cells precedes t cells: Cross talk between the innate and adaptive immune system?
36. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis
37. Requirement for the chemokine receptor CXCR3 for acute allograft rejection
38. Targetting of chemokine receptors CCR2 and CCR5 prolongs murine allograft survival
39. CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection
40. Expression of the C-C chemokine receptor 5 in human kidney diseases
41. CC chemokine receptor 5 and renal-transplant survival
42. RANTES chemokine expression in cell-mediated transplant rejection of the kidney
43. Renal allograft rejection-β chemokine involvement in the development of tubulitis
44. A new class of membrane-bound chemokine with a CX3C motif
45. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion and activation under physiological flow
46. Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection
47. Fractalkine expression in human renal inflammation
48. Fractalkine expression on human renal tubular epithelial cells: Potential role in mononuclear cell adhesion
49. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic allograft rejection
50. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection
51. Potential role for monocyte chemoattractant protein-4 (MCP-4) in monocyte/macrophage recruitment in acute renal inflammation
52. Distinct T cell/renal tubular epithelial cell interactions define different chemokine production: Implications for tubulo-interstitial injury in chronic glomerulonephritides
53. Epithelial derived neutrophil activating factor 78 production in human renal tubule epithelial cells and in renal allograft rejection
54. Interleukin 8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis
55. Interleukin-8 expression in patients after renal transplantation
56. Interleukin-8 serum and urine concentrations after kidney transplantation
57. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: Correlation with transendothelial chemotactic potential
58. Chemokine receptor (CXCR4) mRNA-expressing leukocytes are increased in human renal allograft rejection
59. Localization of C-X-C and C-C chemokines to chemokines to renal tubular epithelial cells in human kidney transplants is not confined to acute cellular rejection
60. Expression of chemokines and chemokine receptors during human renal transplant rejection
61. High expression of chemokines interferon-γ-inducible protein of 10 kDa (IP-10), monokine induced by interferon-γ (Mig) and of their receptor (CXCR3) in acute renal rejection
62. The duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and cresentic glomerulonephritis
63. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment
64. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection